About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Dallas | 13,696 Studies Near You

Clinical TrialsDallas

Clinical Trials in Dallas

Discover 13,696 clinical trials near Dallas, Texas. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 121-140 of 13,696 trials

RecruitingA Study of TRK-950 When Used in Combination With Ramucirumab and Paclitaxel in Patients With Gastric CancerThis study will assess the efficacy, safety, optimal dose and ADA and NAbs development of TRK-950 at two separate dose levels in combination with ramucirumab and paclitaxel…NCT06038578·Duarte, California and 26 others CompletedA Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Participants With Moderate to Severe Plaque PsoriasisThe main purpose of this study is to evaluate the efficacy of ixekizumab dosing regimens in participants with plaque psoriasis.NCT02513550·Birmingham, Alabama and 124 others

Find Trials by Condition in Dallas

Breast Cancerin Dallas Lung Cancerin Dallas Prostate Cancerin Dallas Colorectal Cancerin Dallas Melanomain Dallas Leukemiain Dallas Lymphomain Dallas Pancreatic Cancerin Dallas Ovarian Cancerin Dallas Brain Cancerin Dallas Diabetesin Dallas

Data from ClinicalTrials.govTerms

Not yet recruiting18F-FDG PET/CT for Diagnosis of Diabetic Foot OsteomyelitisDiabetic foot osteomyelitis (DFO) is a bone infection of the foot that can occur in people with diabetes and may lead to serious complications, including amputation.NCT07828691·Dallas, Texas and 3 others

CompletedStudy to Assess Safety, Tolerability and Clinical Activity of BGB-290 in Combination With Temozolomide (TMZ) in Participants With Locally Advanced or Metastatic Solid TumorsThe primary objective of this study was to determine the safety and tolerability of pamiparib, the maximum tolerated dose (MTD) or maximum administered dose (MAD) for pamiparib…NCT03150810·Grand Rapids, Michigan and 21 others

CompletedS0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast CancerRATIONALE: Cholecalciferol may prevent breast cancer in premenopausal women.NCT01097278·Anniston, Alabama and 359 others

CompletedOsteomyelitis: Procalcitonin to Diagnose and Monitor Osteomyelitis (PCT)We plan a cohort study of 40 diabetic patients admitted to Parkland hospital with a foot infection.NCT02308774·Dallas, Texas

CompletedA Research Study Comparing How Well Different Doses of the Medicine NNC0487-0111 Lower Blood Sugar in People With Type 2 DiabetesThe study will look at how well different doses of a new medicine called NNC0487-0111 help lower the blood sugar and body weight in people with type 2 diabetes.NCT06542874·Birmingham, Alabama and 136 others

TerminatedTesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBCCONTESSA is a multinational, multicenter, randomized, Phase 3 study of tesetaxel in patients with HER2 negative, HR positive LA/MBC previously treated with a taxane in the…NCT03326674·Chandler, Arizona and 206 others

CompletedEfficacy and Safety Study of Reslizumab to Treat Eosinophilic Esophagitis in Subjects Aged 5 to 18 YearsThis trial will study three doses of reslizumab versus placebo in children with eosinophilic esophagitis (EE).NCT00538434·Birmingham, Alabama and 36 others

Active not recruitingA Repeat-Dose, Open-Label, Two Arm Safety and Efficacy Study of Two Doses of VP-001 Administered Intravitreally in Participants With Confirmed PRPF31 Mutation-Associated Retinal Dystrophy, Including Participants Previously Treated With VP001This is a Phase 1/2 repeat-dose, open-label, two-arm, parallel group safety and efficacy study of two doses of VP-001 (30 μg and 75 μg) in participants with confirmed PRPF31…NCT06852963·Jacksonville, Florida and 5 others

TerminatedIdentifying Strategies to Curtail Weight Regain After GLP-1 Receptor Agonist Treatment CessationLongitudinal studies show there is a steep increase in weight regain in the first 3-4 months after stopping GLP-1 receptor agonist medications (GLP-1s) and most patients regain…NCT06273163·Dallas, Texas

Active not recruitingBONAPH1DE, A Prospective Observational Study of Patients With Primary Hyperoxaluria Type 1 (PH1)The purpose of this study is to describe the natural history and progression of patients diagnosed with PH1, and to characterize the long-term real-world safety and effectiveness…NCT04982393·Phoenix, Arizona and 29 others

TerminatedClopidogrel and the Optimization of Gastrointestinal Events (COGENT-1)The purpose of the COGENT-1 clinical trial is to determine whether CGT-2168 (clopidogrel and omeprazole) compared to clopidogrel is safe and effective in reducing the incidence of…NCT00557921·Alexander City, Alabama and 490 others

CompletedIrinotecan in Treating Patients With Progressive or Recurrent Malignant GliomaRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00003616·Los Angeles, California and 9 others

CompletedA Study of JZP150 in Adults With Posttraumatic Stress DisorderThis is a 12-week, double-blind, placebo-controlled, randomized, parallel-group, multicenter study of the safety and efficacy of JZP150 in the treatment of adult participants with…NCT05178316·Phoenix, Arizona and 51 others

CompletedEvaluating the Efficacy of Pathways Parent-Mediated Early Autism Intervention on Social Attention and LanguageThe goal of this clinical trial is to compare the efficacy of Pathways parent-mediated early autism intervention (Pathways) and a parent education intervention (PEI) delivered to…NCT05604326·Dallas, Texas

TerminatedA Study to Test if TEV-48574 is Effective in Relieving AsthmaThe primary objective of the study is to evaluate the effect of TEV-48574 compared with placebo on loss of asthma control (LoAC) in adult participants with T2-low and non-T2…NCT04545385·Birmingham, Alabama and 96 others

Active not recruitingExtended Validation of Donor-derived Cell-free DNA in Kidney Transplant RecipientsThis is a multinational, multi-center, observational cohort study. Kidney allograft rejection is poorly detected by standard-of-care biomarkers.NCT07805343·Los Angeles, California and 24 others

CompletedStudy Estimating the Clinical Difference Between 300 mg and 150 mg of Secukinumab Following Dose Escalation to 300 mg in Patients With Ankylosing SpondylitisThis was a study estimating the clinical difference between 300 mg and 150 mg of secukinumab following dose escalation to 300 mg in patients with ankylosing spondylitisNCT03350815·Jonesboro, Arkansas and 64 others

TerminatedBintrafusp Alfa in High Mobility Group AT-Hook 2 (HMGA2) Expressing Triple Negative Breast CancerThe main purpose of this study was to evaluate bintrafusp alfa monotherapy in participants with triple negative breast cancer (TNBC) who express high levels of HMGA2 as determined…NCT04489940·Newark, Delaware and 44 others

PreviousPage 7 of 685Next

Heart Diseasein Dallas